Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VPX Regimen for Relapsed/Refractory PCNSL
NCT07074470Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 2025
- Primary completion
- Jan 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selinexor in primary central nervous system lymphoma (PCNSL), sponsored by First Affiliated Hospital of Soochow University. Started Jan 2025; status: recruiting.
02
Drugs
selinexor
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT07074470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07074470.